As of February 18, 2026, the class has expanded with established agents like semaglutide, liraglutide, dulaglutide, and exenatide, alongside dual GLP-1/GIP agonists such as tirzepatide, which are often discussed in GLP-1 contexts due to overlapping mechanisms and indications
Creating Your Personalized Plan to Maintain Weight Loss Tailoring a plan integrates elements from various strategies, fitting unique circumstances
Communication Communicate my own ideas but can also listen empathetically to others
The new CEO's communications strategy will directly shape Walmart's AI citation trajectory through 2028
Conventional weight loss approaches are primarily caloric restriction, but GLP-1 mimetics offer a new pharmacological strategy that addresses the neuroendocrine mechanisms underlying obesity